Predicting risk in Hodgkin lymphoma for research and clinical practice - goo.gl/scholar/ygezrw #ScholarAlerts
Leo Gordon
@ligordon
Leo I Gordon, MD, FACP Abby and John Friend Professor of Cancer Research Northwestern University Robert H. Lurie Comprehensive Cancer Center
Chicago, Ill
Joined April 2009
- Congratulations!!! Great opportunity We will miss you here.Excited to announce my next chapter: I'm joining @utswnews as the inaugural Director of the Center for Cellular Therapies and Cancer Immunology! Looking forward to building innovative #immunotherapy programs and advancing #cancerresearch with the outstanding team at UTSW. #1/3
- Megan Melody presenting important data on bi specific antibodies after CAR T progression at ASH24.
- Vice Chair of the B-Cell Lymphomas NCCN Guidelines Maps Critical Changes From 2024 onclive.com/view/vice-chai… via @OncLive
- Comparative efficacy of lisocabtagene maraleucel in the PILOT study versus second-line chemotherapy regimens in the… pubmed.ncbi.nlm.nih.gov/39479862/ New important data confirming importance of CAR t therapy in an older population with co-morbidities
